CAB-AXL-ADC Safety and Efficacy Study in Adults With NSCLC


Study Number
1195721
Phase
II
Age Group
Adult
Purpose

The objective of this study is to assess safety and efficacy of CAB-AXL-ADC in NSCLC

Full Title

A PHASE 2 STUDY OF BA3011 ALONE AND IN COMBINATION WITH NIVOLUMAB IN ADULT PATIENTS WITH METASTATIC NON-SMALL CELL LUNG CANCER WHO HAD PRIOR DISEASE PROGRESSION ON A PD-1/L1, EGFR, OR ALK INHIBITOR

ClinicalTrials.Gov ID
NCT04681131

To inquire about participating in these studies, call 1-800-ROSWELL (1-800-767-9355) or e-mail askroswell@roswellpark.org.